Home > News > NanoLogix Study Confirms Early Success Of Hydrogen Bioreactor
May 9th, 2005
NanoLogix Study Confirms Early Success Of Hydrogen Bioreactor
Abstract:
NanoLogix, Inc., a Nanobiotechnology company engaged in the research, development and commercialization of technologies for the production of bacteria and disease testing kits, alternative sources of fuel, cancer therapy and remediation of toxic materials, announces that preliminary data and results of a study which confirms laboratory proof-of-concept measurements
have shown it possible to generate hydrogen in high yields via the use and adaptation of its intellectual property.
Source:
prnewswire
| Related News Press |
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||